Literature DB >> 14585076

Oncogenes as regulators of apoptosis.

Mohamed Labazi1, Andrew C Phillips.   

Abstract

Although cancer is a disease that will afflict one out of three people in the Western world, when considered at a cellular level, it is a rare clonal event. Long-lived organisms, such as humans, have evolved strategies to restrict the development of potentially malignant cells, and one such mechanism is the coupling of proliferative and apoptotic pathways. Multiple oncogenes have the ability to trigger apoptosis when expressed in an inappropriate fashion, and this is thought to restrict tumour formation by eliminating potentially malignant cells that have acquired a mutation stimulating proliferation. Hence for a tumour to arise, in addition to mutations that drive proliferation, mutations that prevent apoptosis are also a prerequisite.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14585076     DOI: 10.1042/bse0390089

Source DB:  PubMed          Journal:  Essays Biochem        ISSN: 0071-1365            Impact factor:   8.000


  4 in total

1.  Caspase-1 is a direct target gene of ETS1 and plays a role in ETS1-induced apoptosis.

Authors:  Huiping Pei; Chunyang Li; Yair Adereth; Tien Hsu; Dennis K Watson; Runzhao Li
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

2.  Malignant phenotype of PC3 cell line was inhibited by siRNA targeting PAR gene.

Authors:  Xiaofeng Xu; Siwei Zhou; Zhengyu Zhang; Jingping Ge; Wen Cheng; Zhifeng Wei; Xu Zhang; Jianping Gao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-08

3.  CSN5/JAB1 interacts with the centromeric components CENP-T and CENP-W and regulates their proteasome-mediated degradation.

Authors:  Younghwa Chun; Miae Lee; Byoungwoo Park; Soojin Lee
Journal:  J Biol Chem       Date:  2013-08-07       Impact factor: 5.157

4.  Genome-wide screening identifies novel genes implicated in cellular sensitivity to BRAFV600E expression.

Authors:  Tengyu Ko; Rahul Sharma; Shisheng Li
Journal:  Oncogene       Date:  2019-09-23       Impact factor: 9.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.